← Latest Filings
C
Casdin Partners Master Fund, L.P.
Open-market buys
20
$47.0M total
Open-market sells
4
$49.5M total
Tracking since
Oct 2025
Activity timeline
Open-market buy — $2.6M
GeneDx Holdings Corp. · Jun 5, 2026
Open-market buy — $8.5M
GeneDx Holdings Corp. · Jun 4, 2026
Open-market trades from the last two years.
Holdings as last reported
72,100,000 Common Stock, $0.001 par value per share in LAB
Held indirectly (See Footnote) · as of 2025-12-04
5,957,165 Common Stock, par value $0.001 per share in BLFS
Held indirectly (Footonote) · as of 2025-10-15
Companies touched
BioLife Solutions, Inc.
CIK 0000834365
STANDARD BIOTOOLS INC.
CIK 0001162194
